You are here

  • Home
  • Online First
  • FIGO 2018 stage IB2 (2–4 cm) Cervical cancer treated with Neo-adjuvant chemotherapy followed by fertility Sparing Surgery (CONTESSA); Neo-Adjuvant Chemotherapy and Conservative Surgery in Cervical Cancer to Preserve Fertility (NEOCON-F). A PMHC, DGOG, GC…

Article info

Article menu

other Versions

Download PDFPDF
Clinical Trial
FIGO 2018 stage IB2 (2–4 cm) Cervical cancer treated with Neo-adjuvant chemotherapy followed by fertility Sparing Surgery (CONTESSA); Neo-Adjuvant Chemotherapy and Conservative Surgery in Cervical Cancer to Preserve Fertility (NEOCON-F). A PMHC, DGOG, GCIG/CCRN and multicenter study

Authors

  1. Correspondence to Dr Marie Plante, Obstetrics and Gynecology, Centre Hospitalier Universitaire de Quebec, Quebec, G1R-2J6, Canada; marie.plante{at}crhdq.ulaval.ca
View Full Text

Citation

Plante M, van Trommel N, Lheureux S, et al
FIGO 2018 stage IB2 (2–4 cm) Cervical cancer treated with Neo-adjuvant chemotherapy followed by fertility Sparing Surgery (CONTESSA); Neo-Adjuvant Chemotherapy and Conservative Surgery in Cervical Cancer to Preserve Fertility (NEOCON-F). A PMHC, DGOG, GCIG/CCRN and multicenter study
International Journal of Gynecologic Cancer Published Online First: 17 May 2019. doi: 10.1136/ijgc-2019-000398

Publication history

  • Accepted April 8, 2019
  • First published May 17, 2019.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© IGCS and ESGO 2019. No commercial re-use. See rights and permissions. Published by BMJ.